

Farther Finance Advisors LLC lifted its position in SPDR S&P Global Infrastructure ETF (NYSEARCA:GII) by 5,749.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,230 shares of the company's stock after acquiring an additional 11,038 shares during the quarter. Farther

Shares of SPDR S&P Global Infrastructure ETF (NYSEARCA:GII - Get Free Report) reached a new 52-week high during trading on Friday. The company traded as high as $72.06 and last traded at $70.92, with a volume of 156 shares. The stock had previously closed at $71.09. SPDR S&P Global Infrastructure ETF Price Performance The

Ideally, thematic ETFs capture long-term secular investment themes not fully represented by broad market or sector-based approaches. The best thematic index implementations make use of quantifiable measures such as revenue and market share to identify companies with meaningful exposure to specific themes.

The article compares SPDR S&P Global Infrastructure ETF (GII) and iShares Global Infrastructure ETF (IGF), both tracking the S&P Global Infrastructure Index. Downgrade to 'hold' due to high prices, stagnating momentum, and increased volatility; a better entry point may come after a price correction. IGF is favored over GII for its superior liquidity and lower expense ratio, despite GII's slightly better risk-adjusted metrics and lower volatility.

GII is a buy for exposure to global infrastructure, benefiting from AI, renewables, and urbanization megatrends driving robust long-term demand. The ETF offers a high dividend yield, resilient industry exposure, and global diversification, positioning it well for future growth. While GII outperforms its peers despite a slightly higher expense ratio and lower liquidity, its concentration and trading volume present moderate risks.

BOTHELL, Wash., April 24, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that its investigative drug candidate CDI-988 was shown to bind to the highly conserved region of the GII.17 protease with excellent potency, similar to that shown across a range of GII.4 norovirus variants that had been the dominant worldwide strains until this year. The high resolution GII.17 protease crystal structures used in determining CDI-988's activity were obtained using the Company's proprietary structure-based platform technology. Cocrystal plans to initiate a human norovirus challenge study in 2025 in the U.S. to evaluate CDI-988 as a potential prevention and treatment of norovirus infection.

Infrastructure is a crucial foundation for any kind of society attempting to expand beyond a handful of individual, nearby homesteads in order to form a community.

The S&P Global Infrastructure ETF offers broad diversification across energy, industrials, utilities, and transportation sectors. Despite its unique portfolio, GII has underperformed compared to sector-specific ETFs and even its rival iShares Global Infrastructure ETF. GII's recent performance shows promise, but its long-term returns have been mediocre, and I'm not convinced that the trend has changed.